首页> 美国卫生研究院文献>other >Rapid Quantitative Chiral Amphetamines Liquid Chromatography-Tandem Mass Spectrometry Method in Plasma and Oral Fluid with a Cost-effective Chiral Derivatizing Reagent
【2h】

Rapid Quantitative Chiral Amphetamines Liquid Chromatography-Tandem Mass Spectrometry Method in Plasma and Oral Fluid with a Cost-effective Chiral Derivatizing Reagent

机译:高效手性衍生试剂用于血浆和口服液中快速定量手性苯丙胺类液相色谱-串联质谱法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Methamphetamine is a widely abused psychostimulant containing a chiral center. Consumption of over-the-counter and prescription medications may yield positive amphetamines results, but chiral separation of l- and d- methamphetamine and its metabolite amphetamine can help determine whether the source was licit or illicit. We present the first LC-MS/MS method with precolumn derivatization for methamphetamine and amphetamine chiral resolution in plasma and oral fluid collected with the Oral-Eze® and Quantisal™ devices. To 0.5 mL plasma, 0.75 mL Oral-Eze, or 1 mL Quantisal specimen racemic d11-methamphetamine and amphetamine internal standards were added, followed by protein precipitation. Samples were centrifuged and supernatants loaded onto pre-conditioned Phenomenex® Strata™-XC Polymeric Strong Cation solid phase extraction columns. After washing, analytes were eluted with 5% ammonium hydroxide in methanol. The eluate was evaporated to dryness and reconstituted in water. Derivatization was performed with 1-fluoro-2,4-dinitrophenyl-5-l-alanineamide (Marfey's reagent) and heating at 45°C for 1 h. Derivatized enantiomer separations were performed under isocratic conditions (methanol:water, 60:40) with a Phenomenex® Kinetex® 2.6 μm C18 column. Analytes were identified and quantified by two MRM transitions and their ratio on a 3200 QTrap (AB Sciex) mass spectrometer in ESI negative mode. In all three matrices, the method was linear for all enantiomers from 1-500 μg/L, with imprecision and accuracy of ≤11.3% and 85.3-108%, respectively. Extraction efficiencies ranged from 67.4-117% and matrix effects from -17.0-468%, with variation always ≤19.1%. Authentic plasma and OF specimens were collected from an IRB-approved study that included controlled Vicks® VapoInhaler™ administration. The present method is sensitive, selective, economic and rapid (separations accomplished in <10 min), and improves methamphetamine result interpretation.
机译:甲基苯丙胺是一种广泛滥用的含有手性中心的精神兴奋剂。消费非处方药和处方药可能会产生阳性的苯丙胺结果,但是手性分离1-甲基苯丙胺和d-甲基苯丙胺及其代谢产物苯丙胺可以帮助确定来源是合法的还是非法的。我们介绍了第一个LC-MS / MS方法,采用Oral-Eze ®和Quantisal™装置收集血浆和口腔液中的甲基苯丙胺和苯丙胺手性拆分,并进行了柱前衍生。向0.5 mL血浆中加入0.75 mL Oral-Eze或1 mL Quantisal外消旋体d11-甲基苯丙胺和苯丙胺内标,然后进行蛋白质沉淀。离心样品,并将上清液加载到预处理的Phenomenex ® Strata™-XC聚合强阳离子固相萃取柱上。清洗后,分析物用5%氢氧化铵的甲醇溶液洗脱。将洗脱液蒸发至干并在水中重构。用1-氟-2,4-二硝基苯基-5-1-丙氨酸酰胺(马菲试剂)进行衍生化,并在45℃加热1小时。使用Phenomenex ® Kinetex ® 2.6μmC18色谱柱在等度条件下(甲醇:水,60:40)进行衍生化对映体分离。在ESI负离子模式下,通过3200 QTrap(AB Sciex)质谱仪上的两个MRM跃迁及其比率鉴定并定量分析物。在所有三种基质中,该方法对于1-500μg/ L的所有对映异构体都是线性的,不精确度和准确度分别≤11.3%和85.3-108%。提取效率范围为67.4-117%,基质效应范围为-17.0-468%,变化始终≤19.1%。真实的血浆和OF标本是从IRB批准的一项研究中收集的,该研究包括控制的Vicks ® VapoInhaler™给药。本方法灵敏,选择性,经济且快速(分离时间少于10分钟),并改进了甲基苯丙胺的结果解释。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号